Submitted by Anonymous (not verified) on 16 October 2024 - 11:28
Human medicines European public assessment report (EPAR): Mevlyq, eribulin, Date of authorisation: 09/02/2024, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mevlyq, eribulin, Date of authorisation: 09/02/2024, Revision: 1, Status: Authorised